KellyEliseDooleyMD
Infectious Disease • Nashville, TNAssistant Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Dooley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Childrens Way
Nashville, TN 37232Phone+1 615-936-2000
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 2005 - 2008- Johns Hopkins UniversityResidency, Internal Medicine, 1999 - 2002
Duke University School of MedicineClass of 1999
Certifications & Licensure
OR State Medical License 2002 - Present
TN State Medical License 2022 - 2025
MD State Medical License 2006 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers Start of enrollment: 2009 Dec 01
- Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers Start of enrollment: 2010 Apr 01
- Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsPopulation Pharmacokinetics of Pyrazinamide in Patients with Tuberculosis.Abdullah Alsultan, Rada M. Savic, Kelly E. Dooley, Marc H Weiner, William C. Whitworth
Antimicrobial Agents and Chemotherapy. 2017-06-01 - 35 citationsPoor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study.Nicole Salazar-Austin, Jennifer D. Hoffmann, Silvia Cohn, Fildah Mashabela, Ziyaad Waja
Clinical Infectious Diseases. 2018-03-05 - 11 citationsOptimising pyrazinamide for the treatment of tuberculosisNan Zhang, Radojka M. Savic, Martin J. Boeree, Charles A. Peloquin, Marc H Weiner
The European Respiratory Journal. 2021-02-04
Journal Articles
- State of the Art Review of HIV‐TB Coinfection in Special PopulationsEthel D Weld, Kelly E Dooley, Clinical Pharmacology & Therapeutics
Press Mentions
Johns Hopkins School of Medicine Among Clinical Trial Sites Testing COVID-19 TherapiesNovember 18th, 2020
Johns Hopkins Researchers to Present Latest Findings on TB and HIV at CROI 2019March 7th, 2019
Tip Sheet: Johns Hopkins Researchers Present at Annual CROI MeetingMarch 1st, 2018
Grant Support
- PK/PD Issues In The Use Of New Therapies For The Treatment Of TuberculosisNational Institute Of Allergy And Infectious Diseases2009–2012
Other Languages
- French
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/kelly-dooley
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
